We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Risk Management Guidances Won't Burden Industry, FDA Says
Risk Management Guidances Won't Burden Industry, FDA Says
April 5, 2005
A trio of final guidance documents focused on developing new ways to minimize the safety risks of prescription drugs and biologics are not expected to lengthen the product-approval process, a top FDA official said.